{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:45:29Z","timestamp":1773168329215,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"DOI":"10.1007\/s12035-024-04421-z","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T04:02:01Z","timestamp":1723435321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Disease Hidden in Plain Sight: Pathways and Mechanisms of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC)"],"prefix":"10.1007","author":[{"given":"Apoorva","family":"Saxena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"4421_CR1","doi-asserted-by":"publisher","unstructured":"Long COVID: let patients help define long-lasting COVID symptoms. Nature 586, 170, https:\/\/doi.org\/10.1038\/d41586-020-02796-2 (2020).","DOI":"10.1038\/d41586-020-02796-2"},{"key":"4421_CR2","doi-asserted-by":"publisher","unstructured":"Perego, E. et al. Why the patient-made term \u2018long covid\u2019 is needed [version 1; peer review: 1 approved with reservations, 1 not approved]. Wellcome Open Research 5, https:\/\/doi.org\/10.12688\/wellcomeopenres.16307.1 (2020).","DOI":"10.12688\/wellcomeopenres.16307.1"},{"key":"4421_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","volume":"15","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S (2021) Long COVID: an overview. Diabetes Metab Syndr 15:869\u2013875. https:\/\/doi.org\/10.1016\/j.dsx.2021.04.007","journal-title":"Diabetes Metab Syndr"},{"key":"4421_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/cvr\/cvac115","volume":"119","author":"M Gy\u00f6ngy\u00f6si","year":"2023","unstructured":"Gy\u00f6ngy\u00f6si M et al (2023) Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc Res 119:336\u2013356. https:\/\/doi.org\/10.1093\/cvr\/cvac115","journal-title":"Cardiovasc Res"},{"key":"4421_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133\u2013146. https:\/\/doi.org\/10.1038\/s41579-022-00846-2","journal-title":"Nat Rev Microbiol"},{"key":"4421_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41420-021-00464-6","volume":"7","author":"E Ortona","year":"2021","unstructured":"Ortona E, Buonsenso D, Carfi A, Malorni W (2021) Long COVID: an estrogen-associated autoimmune disease? Cell Death Discov 7:77. https:\/\/doi.org\/10.1038\/s41420-021-00464-6","journal-title":"Cell Death Discov"},{"key":"4421_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3489","volume":"370","author":"N Nabavi","year":"2020","unstructured":"Nabavi N (2020) Long covid: how to define it and how to manage it. BMJ 370:m3489. https:\/\/doi.org\/10.1136\/bmj.m3489","journal-title":"BMJ"},{"key":"4421_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2023.08.019","volume":"136","author":"S Diexer","year":"2023","unstructured":"Diexer S et al (2023) Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. Int J Infect Dis 136:14\u201321. https:\/\/doi.org\/10.1016\/j.ijid.2023.08.019","journal-title":"Int J Infect Dis"},{"key":"4421_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/infdis\/jiad382","volume":"229","author":"P Hedberg","year":"2023","unstructured":"Hedberg P, Naucl\u00e9r P (2023) Post\u2013COVID-19 condition after SARS-CoV-2 infections during the Omicron surge vs the Delta, Alpha, and wild type periods in Stockholm. Sweden The Journal of Infectious Diseases 229:133\u2013136. https:\/\/doi.org\/10.1093\/infdis\/jiad382","journal-title":"Sweden The Journal of Infectious Diseases"},{"key":"4421_CR10","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/s0140-6736(22)00941-2","volume":"399","author":"M Antonelli","year":"2022","unstructured":"Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ (2022) Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet 399:2263\u20132264. https:\/\/doi.org\/10.1016\/s0140-6736(22)00941-2","journal-title":"Lancet"},{"key":"4421_CR11","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1016\/s2589-7500(23)00056-0","volume":"5","author":"LS Canas","year":"2023","unstructured":"Canas LS et al (2023) Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Lancet Digit Health 5:e421\u2013e434. https:\/\/doi.org\/10.1016\/s2589-7500(23)00056-0","journal-title":"Lancet Digit Health"},{"key":"4421_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M (2022) Pathological sequelae of long-haul COVID. Nat Immunol 23:194\u2013202. https:\/\/doi.org\/10.1038\/s41590-021-01104-y","journal-title":"Nat Immunol"},{"key":"4421_CR13","doi-asserted-by":"publisher","unstructured":"Kempuraj, D. et al. COVID-19 and long COVID: disruption of the neurovascular unit, blood-brain barrier, and tight junctions. Neuroscientist, 10738584231194927, https:\/\/doi.org\/10.1177\/10738584231194927 (2023).","DOI":"10.1177\/10738584231194927"},{"key":"4421_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00405-022-07689-w","volume":"280","author":"HN Krishnakumar","year":"2023","unstructured":"Krishnakumar HN et al (2023) Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic. Eur Arch Otorhinolaryngol 280:505\u2013509. https:\/\/doi.org\/10.1007\/s00405-022-07689-w","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4421_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/qjmed\/hcac272","volume":"116","author":"X Dai","year":"2023","unstructured":"Dai X et al (2023) Neurological complications of COVID-19. QJM 116:161\u2013180. https:\/\/doi.org\/10.1093\/qjmed\/hcac272","journal-title":"QJM"},{"key":"4421_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"J Meinhardt","year":"2021","unstructured":"Meinhardt J et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24:168\u2013175. https:\/\/doi.org\/10.1038\/s41593-020-00758-5","journal-title":"Nat Neurosci"},{"key":"4421_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","volume":"6","author":"L Zhang","year":"2021","unstructured":"Zhang L et al (2021) SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther 6:337. https:\/\/doi.org\/10.1038\/s41392-021-00719-9","journal-title":"Signal Transduct Target Ther"},{"key":"4421_CR18","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1093\/cid\/ciaa995","volume":"73","author":"AJ Zhang","year":"2021","unstructured":"Zhang AJ et al (2021) Severe acute respiratory syndrome coronavirus 2 infects and damages the mature and immature olfactory sensory neurons of hamsters. Clin Infect Dis 73:e503\u2013e512. https:\/\/doi.org\/10.1093\/cid\/ciaa995","journal-title":"Clin Infect Dis"},{"key":"4421_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.bbi.2020.06.032","volume":"89","author":"B Bryche","year":"2020","unstructured":"Bryche B et al (2020) Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun 89:579\u2013586. https:\/\/doi.org\/10.1016\/j.bbi.2020.06.032","journal-title":"Brain Behav Immun"},{"key":"4421_CR20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370:856\u2013860. https:\/\/doi.org\/10.1126\/science.abd2985","journal-title":"Science"},{"key":"4421_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-022-00529-9","volume":"17","author":"R Butowt","year":"2022","unstructured":"Butowt R, von Bartheld CS (2022) The route of SARS-CoV-2 to brain infection: have we been barking up the wrong tree? Mol Neurodegener 17:20. https:\/\/doi.org\/10.1186\/s13024-022-00529-9","journal-title":"Mol Neurodegener"},{"key":"4421_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.674123","volume":"15","author":"K Bilinska","year":"2021","unstructured":"Bilinska K, von Bartheld CS, Butowt R (2021) Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19. Front Cell Neurosci 15:674123. https:\/\/doi.org\/10.3389\/fncel.2021.674123","journal-title":"Front Cell Neurosci"},{"key":"4421_CR23","unstructured":"M Cascella, M. R., A. Aleem, S C Dulebohn and R Di Napoli. Features, evaluation, and treatment of coronavirus (COVID-19), 2023)."},{"key":"4421_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2020.102656","volume":"225","author":"CG Parker","year":"2020","unstructured":"Parker CG, Dailey MJ, Phillips H, Davis EA (2020) Central sensory-motor crosstalk in the neural gut-brain axis. Auton Neurosci 225:102656. https:\/\/doi.org\/10.1016\/j.autneu.2020.102656","journal-title":"Auton Neurosci"},{"key":"4421_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers MM et al (2020) SARS-CoV-2 productively infects human gut enterocytes. Science 369:50\u201354. https:\/\/doi.org\/10.1126\/science.abc1669","journal-title":"Science"},{"key":"4421_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bbi.2021.01.024","volume":"94","author":"Y Shi","year":"2021","unstructured":"Shi Y, Li Z, Yang C, Liu C (2021) The role of gut-brain axis in SARA-CoV-2 neuroinvasion: culprit or innocent bystander? Brain Behav Immun 94:476\u2013477. https:\/\/doi.org\/10.1016\/j.bbi.2021.01.024","journal-title":"Brain Behav Immun"},{"key":"4421_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40779-022-00386-z","volume":"9","author":"Q-L Guo","year":"2022","unstructured":"Guo Q-L et al (2022) Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives. Mil Med Res 9:26. https:\/\/doi.org\/10.1186\/s40779-022-00386-z","journal-title":"Mil Med Res"},{"key":"4421_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41392-021-00818-7","volume":"6","author":"D Wan","year":"2021","unstructured":"Wan D et al (2021) Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther 6:406. https:\/\/doi.org\/10.1038\/s41392-021-00818-7","journal-title":"Signal Transduct Target Ther"},{"key":"4421_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.573095","volume":"11","author":"R Chen","year":"2020","unstructured":"Chen R et al (2020) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 11:573095. https:\/\/doi.org\/10.3389\/fneur.2020.573095","journal-title":"Front Neurol"},{"key":"4421_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/03331024211036665","volume":"42","author":"K Messlinger","year":"2022","unstructured":"Messlinger K, Neuhuber W, May A (2022) Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19. Cephalalgia 42:176\u2013180. https:\/\/doi.org\/10.1177\/03331024211036665","journal-title":"Cephalalgia"},{"key":"4421_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","volume":"92","author":"A Paniz-Mondolfi","year":"2020","unstructured":"Paniz-Mondolfi A et al (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92:699\u2013702. https:\/\/doi.org\/10.1002\/jmv.25915","journal-title":"J Med Virol"},{"key":"4421_CR32","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1021\/acschemneuro.0c00725","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM (2020) Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci 11:4017\u20134020. https:\/\/doi.org\/10.1021\/acschemneuro.0c00725","journal-title":"ACS Chem Neurosci"},{"key":"4421_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)31282-4","volume":"395","author":"CH von Weyhern","year":"2020","unstructured":"von Weyhern CH, Kaufmann I, Neff F, Kremer M (2020) Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet 395:e109. https:\/\/doi.org\/10.1016\/s0140-6736(20)31282-4","journal-title":"Lancet"},{"key":"4421_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-020-02190-2","volume":"140","author":"Z Jaunmuktane","year":"2020","unstructured":"Jaunmuktane Z et al (2020) Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol 140:397\u2013400. https:\/\/doi.org\/10.1007\/s00401-020-02190-2","journal-title":"Acta Neuropathol"},{"key":"4421_CR35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41593-020-00771-8","volume":"24","author":"EM Rhea","year":"2021","unstructured":"Rhea EM et al (2021) The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci 24:368\u2013378. https:\/\/doi.org\/10.1038\/s41593-020-00771-8","journal-title":"Nat Neurosci"},{"key":"4421_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10456-024-09908-w","volume":"27","author":"J Lubell","year":"2024","unstructured":"Lubell J (2024) People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing. Angiogenesis 27:123\u2013124. https:\/\/doi.org\/10.1007\/s10456-024-09908-w","journal-title":"Angiogenesis"},{"key":"4421_CR37","doi-asserted-by":"publisher","unstructured":"Rauti, R. et al. Effect of SARS-CoV-2 proteins on vascular permeability. Elife 10, https:\/\/doi.org\/10.7554\/eLife.69314 (2021).","DOI":"10.7554\/eLife.69314"},{"key":"4421_CR38","doi-asserted-by":"publisher","first-page":"2090792","DOI":"10.1080\/21688370.2022.2090792","volume":"11","author":"L Ashour","year":"2023","unstructured":"Ashour L (2023) Roles of the ACE\/Ang II\/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis. Tissue Barriers 11:2090792. https:\/\/doi.org\/10.1080\/21688370.2022.2090792","journal-title":"Tissue Barriers"},{"key":"4421_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbrc.2022.07.113","volume":"626","author":"JY Choi","year":"2022","unstructured":"Choi JY, Park JH, Jo C, Kim KC, Koh YH (2022) SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells. Biochem Biophys Res Commun 626:66\u201371. https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.113","journal-title":"Biochem Biophys Res Commun"},{"key":"4421_CR40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.stem.2020.10.001","volume":"27","author":"L Pellegrini","year":"2020","unstructured":"Pellegrini L et al (2020) SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell 27:951-961.e955. https:\/\/doi.org\/10.1016\/j.stem.2020.10.001","journal-title":"Cell Stem Cell"},{"key":"4421_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2020.596439","volume":"14","author":"F Deffner","year":"2020","unstructured":"Deffner F et al (2020) Histological evidence for the enteric nervous system and the choroid plexus as alternative routes of neuroinvasion by SARS-CoV2. Front Neuroanat 14:596439. https:\/\/doi.org\/10.3389\/fnana.2020.596439","journal-title":"Front Neuroanat"},{"key":"4421_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbi.2020.05.012","volume":"87","author":"YH Huang","year":"2020","unstructured":"Huang YH, Jiang D, Huang JT (2020) SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun 87:149. https:\/\/doi.org\/10.1016\/j.bbi.2020.05.012","journal-title":"Brain Behav Immun"},{"key":"4421_CR43","doi-asserted-by":"publisher","unstructured":"Leng, A. et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 12, https:\/\/doi.org\/10.3390\/cells12050816 (2023).","DOI":"10.3390\/cells12050816"},{"key":"4421_CR44","doi-asserted-by":"publisher","unstructured":"Ong, I. Z., Kolson, D. L. & Schindler, M. K. Mechanisms, effects, and management of neurological complications of post-acute sequelae of COVID-19 (NC-PASC). Biomedicines 11, https:\/\/doi.org\/10.3390\/biomedicines11020377 (2023).","DOI":"10.3390\/biomedicines11020377"},{"key":"4421_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12916-021-02228-6","volume":"20","author":"FJ Ryan","year":"2022","unstructured":"Ryan FJ et al (2022) Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med 20:26. https:\/\/doi.org\/10.1186\/s12916-021-02228-6","journal-title":"BMC Med"},{"key":"4421_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C et al (2022) Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 23:210\u2013216. https:\/\/doi.org\/10.1038\/s41590-021-01113-x","journal-title":"Nat Immunol"},{"key":"4421_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.922422","volume":"12","author":"MAF Queiroz","year":"2022","unstructured":"Queiroz MAF et al (2022) Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol 12:922422. https:\/\/doi.org\/10.3389\/fcimb.2022.922422","journal-title":"Front Cell Infect Microbiol"},{"key":"4421_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2022.0123","volume":"83","author":"S Arun","year":"2022","unstructured":"Arun S, Storan A, Myers B (2022) Mast cell activation syndrome and the link with long COVID. Br J Hosp Med (Lond) 83:1\u201310. https:\/\/doi.org\/10.12968\/hmed.2022.0123","journal-title":"Br J Hosp Med (Lond)"},{"key":"4421_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijid.2021.09.043","volume":"112","author":"LB Weinstock","year":"2021","unstructured":"Weinstock LB et al (2021) Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis 112:217\u2013226. https:\/\/doi.org\/10.1016\/j.ijid.2021.09.043","journal-title":"Int J Infect Dis"},{"key":"4421_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746021","volume":"12","author":"BK Patterson","year":"2021","unstructured":"Patterson BK et al (2021) Persistence of SARS CoV-2 S1 Protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol 12:746021. https:\/\/doi.org\/10.3389\/fimmu.2021.746021","journal-title":"Front Immunol"},{"key":"4421_CR51","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1038\/s41467-022-34068-0","volume":"13","author":"MM Etter","year":"2022","unstructured":"Etter MM et al (2022) Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun 13:6777. https:\/\/doi.org\/10.1038\/s41467-022-34068-0","journal-title":"Nat Commun"},{"key":"4421_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.it.2022.02.008","volume":"43","author":"MJ Peluso","year":"2022","unstructured":"Peluso MJ, Deeks SG (2022) Early clues regarding the pathogenesis of long-COVID. Trends Immunol 43:268\u2013270. https:\/\/doi.org\/10.1016\/j.it.2022.02.008","journal-title":"Trends Immunol"},{"key":"4421_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100100","volume":"4","author":"G Wallukat","year":"2021","unstructured":"Wallukat G et al (2021) Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 4:100100. https:\/\/doi.org\/10.1016\/j.jtauto.2021.100100","journal-title":"J Transl Autoimmun"},{"key":"4421_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100288","volume":"2","author":"E Song","year":"2021","unstructured":"Song E et al (2021) Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med 2:100288. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100288","journal-title":"Cell Rep Med"},{"key":"4421_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang EY et al (2021) Diverse functional autoantibodies in patients with COVID-19. Nature 595:283\u2013288. https:\/\/doi.org\/10.1038\/s41586-021-03631-y","journal-title":"Nature"},{"key":"4421_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2022.103071","volume":"245","author":"M Jammoul","year":"2023","unstructured":"Jammoul M et al (2023) Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Auton Neurosci 245:103071. https:\/\/doi.org\/10.1016\/j.autneu.2022.103071","journal-title":"Auton Neurosci"},{"key":"4421_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103445","volume":"22","author":"FS Seibert","year":"2023","unstructured":"Seibert FS et al (2023) Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Autoimmun Rev 22:103445. https:\/\/doi.org\/10.1016\/j.autrev.2023.103445","journal-title":"Autoimmun Rev"},{"key":"4421_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.597","volume":"10","author":"M Meng","year":"2022","unstructured":"Meng M et al (2022) COVID-19 associated EBV reactivation and effects of ganciclovir treatment. Immun Inflamm Dis 10:e597. https:\/\/doi.org\/10.1002\/iid3.597","journal-title":"Immun Inflamm Dis"},{"key":"4421_CR59","doi-asserted-by":"publisher","unstructured":"Gold, J. E., Okyay, R. A., Licht, W. E. & Hurley, D. J. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 10, https:\/\/doi.org\/10.3390\/pathogens10060763 (2021).","DOI":"10.3390\/pathogens10060763"},{"key":"4421_CR60","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su Y et al (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185:881-895.e820. https:\/\/doi.org\/10.1016\/j.cell.2022.01.014","journal-title":"Cell"},{"key":"4421_CR61","doi-asserted-by":"publisher","unstructured":"Ruiz-Pablos, M., Paiva, B., Montero-Mateo, R., Garcia, N. & Zabaleta, A. Epstein-Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Frontiers in Immunology 12, https:\/\/doi.org\/10.3389\/fimmu.2021.656797 (2021).","DOI":"10.3389\/fimmu.2021.656797"},{"key":"4421_CR62","doi-asserted-by":"publisher","unstructured":"Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. medRxiv, https:\/\/doi.org\/10.1101\/2022.08.09.22278592 (2022).","DOI":"10.1101\/2022.08.09.22278592"},{"key":"4421_CR63","doi-asserted-by":"publisher","unstructured":"Lai, Y. J. et al. Biomarkers in long COVID-19: a systematic review. Front Med (Lausanne) 10, 1085988, https:\/\/doi.org\/10.3389\/fmed.2023.1085988 (2023).","DOI":"10.3389\/fmed.2023.1085988"},{"key":"4421_CR64","doi-asserted-by":"publisher","first-page":"12420","DOI":"10.1038\/s41598-023-39049-x","volume":"13","author":"Y L\u00f3pez-Hern\u00e1ndez","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez Y et al (2023) The plasma metabolome of long COVID patients two years after infection. Sci Rep 13:12420. https:\/\/doi.org\/10.1038\/s41598-023-39049-x","journal-title":"Sci Rep"},{"key":"4421_CR65","doi-asserted-by":"publisher","first-page":"1341843","DOI":"10.3389\/fimmu.2024.1341843","volume":"15","author":"S Saito","year":"2024","unstructured":"Saito S et al (2024) Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front Immunol 15:1341843. https:\/\/doi.org\/10.3389\/fimmu.2024.1341843","journal-title":"Front Immunol"},{"key":"4421_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbi.2023.10.016","volume":"115","author":"S Chen","year":"2024","unstructured":"Chen S et al (2024) Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun 115:209\u2013222. https:\/\/doi.org\/10.1016\/j.bbi.2023.10.016","journal-title":"Brain Behav Immun"},{"key":"4421_CR67","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/brain\/awab148","volume":"144","author":"KT Thakur","year":"2021","unstructured":"Thakur KT et al (2021) COVID-19 neuropathology at Columbia University Irving Medical Center\/New York Presbyterian Hospital. Brain 144:2696\u20132708. https:\/\/doi.org\/10.1093\/brain\/awab148","journal-title":"Brain"},{"key":"4421_CR68","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","volume":"110","author":"M Monje","year":"2022","unstructured":"Monje M, Iwasaki A (2022) The neurobiology of long COVID. Neuron 110:3484\u20133496. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.006","journal-title":"Neuron"},{"key":"4421_CR69","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","volume":"20","author":"E Pretorius","year":"2021","unstructured":"Pretorius E et al (2021) Persistent clotting protein pathology in long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 20:172. https:\/\/doi.org\/10.1186\/s12933-021-01359-7","journal-title":"Cardiovasc Diabetol"},{"key":"4421_CR70","doi-asserted-by":"crossref","unstructured":"Grobbelaar, L. M. et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep 41, 10.1042\/bsr20210611 (2021).","DOI":"10.1042\/BSR20210611"},{"key":"4421_CR71","doi-asserted-by":"publisher","unstructured":"Ryu, J. K. et al. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. bioRxiv, https:\/\/doi.org\/10.1101\/2021.10.12.464152 (2021).","DOI":"10.1101\/2021.10.12.464152"},{"key":"4421_CR72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/atvbaha.120.315338","volume":"41","author":"EG Bouck","year":"2021","unstructured":"Bouck EG et al (2021) COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity. Arterioscler Thromb Vasc Biol 41:401\u2013414. https:\/\/doi.org\/10.1161\/atvbaha.120.315338","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4421_CR73","doi-asserted-by":"publisher","unstructured":"Jana, A. K., Greenwood, A. B. & Hansmann, U. H. E. Presence of a SARS-COV-2 protein enhances amyloid formation of serum amyloid A. bioRxiv, https:\/\/doi.org\/10.1101\/2021.05.18.444723 (2021).","DOI":"10.1101\/2021.05.18.444723"},{"key":"4421_CR74","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. The Lancet Neurology 19:919\u2013929. https:\/\/doi.org\/10.1016\/S1474-4422(20)30308-2","journal-title":"The Lancet Neurology"},{"key":"4421_CR75","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Casta\u00f1eda, A. et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv, https:\/\/doi.org\/10.1101\/2022.01.07.475453 (2022).","DOI":"10.1101\/2022.01.07.475453"},{"key":"4421_CR76","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1038\/s41380-022-01786-2","volume":"27","author":"Samudyata","year":"2022","unstructured":"Samudyata et al (2022) SARS-CoV-2 promotes microglial synapse elimination in human brain organoids. Mol Psychiatry 27:3939\u20133950. https:\/\/doi.org\/10.1038\/s41380-022-01786-2","journal-title":"Mol Psychiatry"},{"key":"4421_CR77","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/s1474-4422(24)00178-9","volume":"23","author":"D Bonhenry","year":"2024","unstructured":"Bonhenry D et al (2024) SARS-CoV-2 infection as a cause of neurodegeneration. Lancet Neurol 23:562\u2013563. https:\/\/doi.org\/10.1016\/s1474-4422(24)00178-9","journal-title":"Lancet Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04421-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04421-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04421-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T16:15:51Z","timestamp":1723479351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04421-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":77,"alternative-id":["4421"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04421-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors listed hereby confirmed that in the above research, there were no human participants and\/or animals involved in any kind of determination, evaluation, or research studies. We confirm that the above-mentioned manuscript has not been previously published and is not under consideration in the same or substantially similar form in any other peer-reviewed media.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}